Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence

NCT03015246 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Heroin Dependence
Opioid Use Disorder

Interventions

DRUG: Extended release morphine
DRUG: Buprenorphine/Naloxone low dose
DRUG: Buprenorphine/Naloxone moderate dose
DRUG: Buprenorphine/Naloxone high dose
DRUG: Active stressor
DRUG: Placebo stressor

Sponsor

Wayne State University